Case Study 3: eCTD Conversion and Submission
The Client...
- a global pharmaceutical company that had recently completed a US eCTD filing
- was looking to prepare their first eCTD submission in Europe for a novel formulation in a new indication
- needed a medical writing and project management resource with in depth knowledge of European CTD requirements to integrate with project teams on both sides of the Atlantic
...so what we did was...
- develop and manage the project timelines and milestones from the medical writing perspective
- write, edit and QC the Clinical modules of the CTD, and check the Quality and Nonclinical modules for compliance and consistency
- liaise with all team members and key internal reviewers to facilitate the review process and keep the project on track
- work with the Client's document management groups to compile and validate the eCTD in accordance with EU guidance
...and the outcome was...
- the EU eCTD was submitted on time and approval has been obtained
- the Client's US team gained a better understanding of EU requirements for future CTD preparation
- global working was improved within the Client
- Spectrum has since worked with the Client on several spin-off projects as their medical writing providers of choice
Read about these services
©2011 Spectrum Regulatory Solutions
Spectrum Regulatory Solutions, Fraser House, 14 Carfax, Horsham, West Sussex RH12 1DZ regulate@spectrumrs.com. Spectrumrs.com is the trading name of Spectrum Regulatory Solutions Ltd. Spectrum Regulatory Solutions is a limited company registered in England and Wales with company number 5331222. Registered office: St James's House, 8 Overcliffe, Gravesend, Kent DA11 0HJ. VAT registration no: 818283318